NEVVI Medicare utilization intelligence

← back

DEGREEN, HYATTD.O. NPI 1235345596 Clinician

Medical Oncology · LANCASTER, PA

Specialty Medical Oncology — from billed Medicare claims
Trained PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE — medical school, self-reported to CMS
In practice about 24 years since medical school (class of 2002, self-reported to CMS)
Location LANCASTER, PA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 56 codes billed · 77,385 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
LANCASTER CANCER CENTER LTD
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-05

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
80053 Blood test, comprehensive group of blood chemicals
83615 Lactate dehydrogenase (enzyme) level
84100 Phosphate level
84550 Uric acid level, blood
82977 Glutamyltransferase (liver enzyme) level
J1626 Injection, granisetron hydrochloride, 100 mcg
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
J3475 Injection, magnesium sulfate, per 500 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
82728 Ferritin (blood protein) level
84466 Transferrin (iron binding protein) level
83540 Iron level
83735 Magnesium level
82378 Carcinoembryonic antigen (cea) protein level
96361 Infusion into a vein for hydration, each additional hour
85046 Red blood count automated, with additional calculations
J1200 Injection, diphenhydramine hcl, up to 50 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
84443 Blood test, thyroid stimulating hormone (tsh)
84439 Thyroxine (thyroid chemical), free
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
82306 Vitamin d-3 level
96417 Administration of additional new drug or substance into vein, 1 hour or less
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
J3490 Unclassified drugs
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J7030 Infusion, normal saline solution , 1000 cc
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96360 Infusion into a vein for hydration, 31-60 minutes
96523 Irrigation of implanted venous access drug delivery device
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
38221 Biopsy of bone marrow
99453 Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.